For instance, the knockdown of Smarcc1, Smarcd1, or Smarcd2 impaired the survival of mouse AML cells, confirming their tumor-maintaining role in this tumor type [51, 85]. The gene discussed is SMARCC1; the disease is acute myeloid leukemia.